ACADIA Pharmaceuticals Inc. vs Star Bulk Carriers Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Star Bulk Carriers Corp trades at $28 (market cap $3.09B). The key difference: ACADIA Pharmaceuticals Inc. is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.79% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | SBLK | |
|---|---|---|
Market Cap | $5.07B | $3.09B |
Sector | Health | Industrials |
52-Week High | $29.41 | $29.15 |
52-Week Low | $20.06 | $16.79 |
Enterprise Value | $4.19B | $3.77B |
Dividend Yield | — | 6.79% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →